Avoiding US FDA Import Alerts in Shrimp and Seafood Supply Chains

The US Food and Drug Administration (FDA) can issue import alerts to detect safety issues with imported seafood. These alerts mean products can be subject to detention without physical examination (DWPE) on arrival in the country, causing disruption to market access and potentially leading to commercial consequences. For these reasons, a thorough understanding of FDA import alert risks is critical to mitigating potential risks.

This webinar explores the key factors influencing US FDA import alerts, with practical examples and insights from our food safety experts. Common causes of shrimp refusals and strategies to strengthen regulatory compliance will be presented, alongside food safety culture, Salmonella risk management, antibiotic and drug residue concerns, sulfite-related challenges and effective sampling and testing practices.

By strengthening compliance knowledge and regulatory oversight, you can mitigate common import alert risks and support conformity with FDA food safety requirements across the supply chain. Our services help your business reduce the risk of regulatory penalties and delays, supporting more efficient market access for your shrimp and seafood products.

Agenda

• Introduction
• FDA shrimp refusal and detention trends
• Regulatory developments and enforcement updates
• Food safety culture and Salmonella risk management
• Sulfite, labeling and regulatory considerations
• Antibiotic and drug residue risks
• Sampling, testing and laboratory best practices
• FDA expectations and result interpretation
• Q&A

Who should attend

This webinar is intended for shrimp producers and harvesters, shrimp processors and exporters, seafood importers, sourcing professionals and end-user buyers, as well as other stakeholders across the farm-raised seafood supply chain serving the US market.